-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Canopy Growth Stock Has Gone Up in Smoke
The cannabis stock frenzy has ended and now realism has set in. Now the CGC bulls must earn the market's trust once again.
Aleafia’s Announcement Should Concern Aphria Stock Investors
The lack of clarity regarding the Aleafia agreement is yet another reason Aphria stock holders should be concerned.
Avoid Cronos Group Stock Even After Yesterday’s Cannabis Carnage
Health impact of vaping makes CRON stock a concern from a regulatory and growth perspective. Keep it on the investment radar, but shares aren't likely to trend higher anytime soon.
Is Aurora Cannabis’ Growth Strategy Enough to Turn Around ACB Stock?
Global operations and distribution are a large part of Aurora's strategy. Will it be enough to turn around the decline of ACB stock?
Here’s How the Mandela Effect Has Hurt Cronos Group Stock
Hysteria over the vaping crisis has hurt CRON stock. But investors should have patience until all the facts are straightened out.
Aurora Cannabis Stock Is Down, But Not Dead
As cannabis stocks have come back down to Earth, darlings like ACB stock have taken a hit. But the future for Aurora Cannabis looks bright.
Square (SQ Stock) Disrupts Yet Another Industry
Square is a dream come true for small business owners. And, as of Thursday, that’s now true for a whole new (and red-hot) market: cannabidiol (CBD).
Investors Should Wait to Buy Canopy Growth Stock Until Profits Appear
Canopy Growth stock continues to falter. Its operating losses and acquisitions continue to bleed its value. Wait for profits to show up.
Hold Your Nose and Buy Canopy Growth Stock
CGC stock has continued to slide since a Bank of America downgrade in late September. But even the analyst that downgraded the stock admits the long-term outlook for Canopy is bullish.
I’m Recommending Canopy Growth Stock… but Not for the Reason You Think
Owning CGC stock is a legalized-cannabis play, of course – but could it also be a sports-nutrition play?
Will Federal Legalization Occur in Time to Save Aurora Cannabis Stock?
ACB stock needs enough cash to reach 2021, when the market for recreational marijuana may open wider in the U.S.
Don’t Expect a Sharp Reversal in Aurora Cannabis Stock
Investors should expect medicinal cannabis growth to slow, extending the cash burn of ACB stock. For now, long-term investors should avoid it.
Why Investors Should Continue to Avoid Cronos Stock
Long-term upside in CRON stock is compelling, but the bull thesis lacks conviction and clarity at the current moment.
What Canopy Growth Stock Needs to Rally
CGC stock is in decline, touching an 18-month low this week. The pressure on Canopy Growth stock will continue until the company responds.
Should Contrarian Investors Buy Aurora Cannabis Stock in October?
ACB stock's struggle with profitability reflects the overall headwinds faced by the entire cannabis industry.
